Literature DB >> 1377893

C-erbB-2 expression in squamous cell carcinoma of the head and neck.

J K Field1, D A Spandidos, M Yiagnisis, J R Gosney, K Papadimitriou, P M Stell.   

Abstract

Seventy-five squamous cell carcinomas of the head and neck were analysed for c-erbB-2 expression using immunohistochemical techniques with four different c-erbB-2 antibodies. No membrane staining was seen in any of the squamous cell carcinomas studied with any of the antibodies; however, c-erbB-2 cytoplasmic staining was seen in 60 per cent of the tumours. The significance of cytoplasmic staining is discussed and that it may possibly represent elevated c-erbB-2 expression in squamous cell carcinomas. C-erbB-2 cytoplasmic staining was also observed in 10 of 23 normal specimens obtained from the resection margin of the tumours. No correlations were found between positive c-erbB-2 cytoplasmic staining and any of the clinicopathological parameters or survival.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377893

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Her-2 immunohistochemical expression in oral squamous cell carcinomas is associated with polysomy of chromosome 17, not Her-2 amplification.

Authors:  Dimitrios Papavasileiou; Konstantinos Tosios; Panos Christopoulos; Nikolaos Goutas; Dimitrios Vlachodimitropoulos
Journal:  Head Neck Pathol       Date:  2009-08-22

Review 2.  The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma.

Authors:  J K Field
Journal:  J R Soc Med       Date:  1995-01       Impact factor: 5.344

3.  Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.

Authors:  P O-charoenrat; P Rhys-Evans; W J Court; G M Box; S A Eccles
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 4.  The role of epidermal growth factor receptor in head and neck squamous cell carcinoma.

Authors:  Rebecca G Pomerantz; Jennifer Rubin Grandis
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

5.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

6.  [Evaluation of her-2/neu amplification/overexpression in OSCC with fluorescence in situ hybridization (FISH) and immunohistochemistry].

Authors:  M Scheer; W Prange; K Petmecky; P Schirmacher; J E Zöller; A C Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  2003-03-07

7.  Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.

Authors:  Mikiko Takikita; Ran Xie; Joon-Yong Chung; Hanbyoul Cho; Kris Ylaya; Seung-Mo Hong; Christopher A Moskaluk; Stephen M Hewitt
Journal:  J Transl Med       Date:  2011-07-29       Impact factor: 5.531

8.  Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study.

Authors:  M Guerry; L Vabre; M Talbot; G Mamelle; A M Leridant; C Hill; J Bosq; B Luboinski; F Janot
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

9.  A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.

Authors:  M E Christensen; F Engbaek; M H Therkildsen; P Bretlau; E Nexø
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

10.  Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma.

Authors:  Bijan Khademi; Behzad Khademi; Abbas Ghaderi; Seyd Fakhroddin Hosseini; Nika Niknejad
Journal:  Iran J Otorhinolaryngol       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.